NLRP3 and Hepatic fibrosis: Here we examine whether NLRP3 inhibition modulates age‐ and alcohol‐induced liver fibrosis by evaluating the efficacy of MCC950, a small‐molecule NLRP3 inhibitor (Coll et al., 2015, 2019).